Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 04/29/25
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract CancerPRNewsWire • 04/25/25
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse GliomaPRNewsWire • 04/23/25
Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing StreakZacks Investment Research • 04/23/25
JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?Zacks Investment Research • 04/21/25
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play OutSeeking Alpha • 04/09/25
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare ConferencePRNewsWire • 03/26/25
Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect?Zacks Investment Research • 03/19/25
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual MeetingPRNewsWire • 03/19/25
Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy PointsInvestors Business Daily • 03/17/25
Follow the Leader: 2 Biopharma Stocks Showing Relative Strength in 2025Zacks Investment Research • 03/13/25
CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRXBusiness Wire • 03/11/25
4 Discounted PEG Stocks Offering the Best Returns to Value InvestorsZacks Investment Research • 03/10/25